April 2003

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-04-02-2003, Volume 27, Issue 4

Pharmaceutical science & technology news.

Related Content:

Industry NewsQuality SystemsPharmaceutical Technology-04-02-2003
FDA Reports on Status of Postmarketing Requirements and Postmarketing Commitments
Novartis’ Radioligand Therapy Gains FDA Nod for Pediatric Patients
Navigating an Uncertain Regulatory Environment for mRNA-based Products